CEL-SCI plummets 43% after phase 3 immunotherapy data misses primary endpoint
June 28 2021 - 11:43AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Apr 2023 to Apr 2024